Dr. Karen Olivia Bazzo Goulart currently working as Lecturer for undergraduate and postgraduate courses at Faculdades de Caxias do Sul and teaches courses in health, brazil and Coordinates short courses and guides course completion work. She did PhD in Biotechnology from the University of Caxias do Sul, MS in Health Sciences with emphasis in Biochemical and Molecular Pharmacology from the Pontifical Catholic University of Rio Grande do Sul, graduated in Biomedicine with emphasis in Clinical Pathology from Feevale University. She is a reviewer of the AIDS CARE journals, World Research Journal of Obstetrics and Gynecology, British Journal of Medicine and Medical Research, and is a member of the editorial board of the journals Oncology Report and Reviews and SM Journal of Gynecology and Obstetrics.
Her research interest focuses on Molecular Nanotechnology and Nanomedicine, Gynecology and Obstetrics , Clinical Pathology, Molecular Pharmacology
Anvarhusein A. Isab
Professor, Saudi Arabia
Anvarhusein A. Isab
University:King Fahd University of Petroleum & Minerals
Dr. Anvarhusein A. Isab is a Professor in Chemistry Department at King Fahd University of Petroleum & Minerals, Saudi Arabia. He did his PhD in Bio-Inorganic Chemistry from Birkbeck College, University of London, UK. He did his degree in Science College, Chem.(Special ) Valsad, India .He has published many papers in national and international journals . He had several awards among some are The Best Research Award , Alberta Heritage Foundation for Medical Research Fellowship, The best Project award, Title: "Solid-state NMR study of Silver (I) complexes with some sulphur containing biologically important ligands. He had many patent issues and severals in pipe-line
His research interest are involved in the synthesis of new Bio-Inorganic Organo-metallic and Polymeric nature type new complexes. These complexes are useful in various field of chemistry. Some of the gold and platinum complexes are being tested for their anti-cancer activities
Assoc. Prof., Australia
University:The University of Western Australia
Dr. Pilar Blancafort is currently an associate professor of Cancer Epigenetics at The University of Western Australia. Her academic background involved undergraduate (Universitat de Barcelona, Spain) and graduate (Universite de Montreal, Canada) degrees in Biochemistry and Molecular Biology, followed by a post-doctoral fellowship with the Barbas laboratory at the Scripps Research Institute (La Jolla, USA). In 2005, she established her own laboratory at the University of North Carolina at Chapel Hill, as Assistant Professor and later as tenured Associate Professor in 2011. In 2012, Professor Blancafort moved her laboratory at the University of Western Australia, School of Human Sciences. Her laboratory focuses on the intersection between cancer genomics and molecular cancer therapeutics. The Blancafort lab has pioneered the development of (epi)genome editing and nanotechnology approaches to target cancers that are currently refractory to treatment and associated with poor outcomes, such as triple negative basal-like breast cancers. She joined the Harry Perkins Institute of Medical Research in 2014. She hold’s a Cancer Council of Western Australia (CCWA) and Australian Research Council (ARC) Future Fellowship.
Her research interests focuses on Breast and ovarian cancer, epigenetics, metastases, molecular cancer therapeutics, genome engineering, CRISPRCas9
Paul Eduard Sijens
Assoc. Prof., Netherlands
Paul Eduard Sijens
Department:Department of of Radiology
University:University Medical Center Groningen
Paul E. Sijens, born in 1959 in the Netherlands, obtained his PhD in 1988. The chapters of his thesis "31P NMR spectroscopy of tumors in the evalu¬ation of respon¬se to therapy" (University of Utrecht) were published in Cancer Research (2x), International Journal of Hyperthermia, NMR in Biomedicine (2x) and Radiology. After having worked as project scientist in Utrecht from 1983-1989, he did a postdoc at Cleveland Clinic Foundation in the group of Dr. Thian Ng (1989-1991). The resultant 31P and 19F MR spectroscopy studies were published in Cancer Research, Magnetic Resonance in Medicine, Magnetic Resonance Imaging and Investigative Radiology. From 1991-2000 he was in charge of clinical MR spectroscopy at Daniel den HoedCancerCenter (Department of Radiolo¬gy, Chairman: dr. M Oudkerk). Since 2000 he has been responsible for MRI research at the Department of Radiology, University Medical Center Groningen (prof. dr. R.A. Dierckx)In charge of experimental and preclinical MR imaging with main focus on neuro-, breast- cardio- and liver MR applications and on quantitative image analysis and segmentation. Since 2002 he has been associate professor at University of Groningen (RUG). His current functions include faculty membership of the European School of Radiology (ESOR), board membership of Research Foundation Flanders.He is author of 125 international scientific papers cited 2182 times (with Hirsch index 27).
His research interest currently focuses on MR imaging and its applications in areas of Neurology, Breast Cancer, Cardiology, and Hepatology and on quantitative image analysis and segmentation.
Dr. Chung is currently a senior faculty member of the Department of Oncology. He was the Chief of Division of Carcinogenesis and Molecular Epidemiologist and the Program Leader of Mechanisms of Carcinogenesis at the American Health Foundation Cancer Center of Institute for Cancer Prevention in Valhalla, New York. He served on various NIH Scientific Review Committees and was a regular member of the NIH Chemical Pathology Study Section (1990-94). He was also a member of the Senior Advisory Board of the Institute for Cancer Prevention (1995-2004). He served on the editorial board for several journals. At Georgetown, He is a tenured professor of the Department of Oncology and a member of the LCCC Carcinogenesis, Biomarkers, and Epidemiology (CBE) Program. He is also a co-leader for that program at the Cancer Center. He is course director and lecturer of Molecular Epidemiology of Cancer Risk (TBIO 581), a course designed to introduce students to the concept of the carcinogenesis process and use of biomarkers to assess cancer risk in human populations.
Research interests are focuses on the mechanism of chemical carcinogenesis and cancer chemoprevention.
Assistant Professor, UK
University:University of Athens
Dr Athanasios Papatsoris graduated from Patras School of Medicine with an honorary scholarship and from the same University he obtained a Master of Science (MSc) in Pathobiochemistry with a thesis in benign prostatic hyperplasia (BPH). His PhD thesis in bladder cancer was completed in the 2nd Department of Urology of Athens University. He was trained in Urology in London and in Athens, where he was certified as an Urological Surgeon. Thereafter, he completed in London a two year Endourology fellowship, officially recognized by the Endourological Society. Also, he completed a clinical fellowship in laparoscopy in Le Mans, France, supported by the European Urological Scholarship Programme (EUSP). Furthermore, for one year he served as an honorary Consultant in Urology at Royal London Hospital, Barts Health NHS Trust. He obtained his fellow of the European Board of Urology (FEBU) degree in Athens and since then he is a FEBU examiner.
Currently, Dr Athanasios Papatsoris is an Assistant Professor of Urology at the 2nd Department of Urology, School of Medicine, Sismanoglio General Hospital, Athens Greece. Moreover, he is an Associate Board member of the EAU Section of Urolithiasis (EULIS), Board member of the EAU Young Academic Urologist (Endourology Group) and European Board of Urology (EBU) National Delegate. Also, he is the Assistant Secretary of the Hellenic (Greek) Urological Association (HUA) and Board member of the HUA Section of Endourology – Laparoscopic Surgery and Urotechnology. Furthermore, he is a Board member of the Institute of Molecular Medicine and & Biomedical Research (IMIBE) as well as the Hellenic Genito-Urinary Cancer Group (HGUCG).
Dr. Papatsoris has more than 125 publications in Pub Med indexed journals and is a member of the Editorial Board of 9 Urology journals. Lastly, he has participated as faculty in several international congresses, workshops and intensive courses (e.g. IRCAD-France).
His research interests focuses in Endourology, lithiasis, laparoscopy, prostate cancer.